Workshop 9: Clinical pharmacology principles to guide prescribing and deprescribing for multimorbid older people
Tracks
Track 3
| Monday, July 13, 2026 |
| 9:00 AM - 11:00 AM |
Details
This workshop, led by the Geriatric Committee of the IUPHAR Clinical and Translational Section, will demonstrate and discuss international approaches to using clinical pharmacology principles to optimise prescribing for older people.
The panel of six international experts, with expertise in clinical pharmacology, geriatric medicine and clinical pharmacy, will first outline their practice and guiding principles/strategies they use for medication optimisation.
They will then demonstrate their insights through presentation and discussion of management of three older patients from three different countries, with one seen in primary care, one in a nursing home and one in an acute hospital.
Workshop attendees will engage with the management decisions, facilitated by questions posed by presenters/chairs enabled by smartphone tools like ‘Mentimeter’, and by questions from attendees to panel members.
The importance of clinical pharmacology prescribing principles when applying the limited evidence to optimising prescribing in these complex patients will be highlighted.
Speaker
Prof. Dr. Petra Thürmann
Chair
University Witten/Herdecke
Panelist
Biography
Prof. Dr. Petra A. Thürmann, MD, is Director of the Philipp Klee-Institute of Clinical Pharmacology, Helios University Clinic Wuppertal, Germany. Since 2021 she is Vice-President of the University of Witten/Herdecke.
After studies of Medicine at the Johann Wolfgang Goethe-University in Frankfurt/Main she received a board certified specialist’s degree in Clinical Pharmacology in 1992 and PhD (Habilitation) in 1997. In 1997 appointment at the HELIOS University Clinic in Wuppertal and 1998 at the University of Witten/Herdecke.
Petra Thürmann was member of the Executive Committee of IUPHAR between 2004 and 2018. She is member of the Drug Commission of the German Medical Association, served from to 2011 until 2023 at the Advisory Council on the Assessment of Developments in the Health Care System (German Ministry of Health) and belongs since 2023 to the Expert Advisory Council “Health and Resilience” of the Federal Government of Germany.
Her research interest is focused on geriatric pharmacotherapy (e.g. PRISCUS list), drug therapy safety as well as gender medicine.
Session chair
Sarah Hilmer
Kolling Institute, Royal North Shore Hospital, NSLHD and University of Sydney
Nashwa Masnoon
Kolling Institute Of Research, University Of Sydney And Northern Sydney Local Health District
